Bitesize Education

Explore expert insights and educational material on CAR T-cell therapy and access up-to-date information on non-Hodgkin lymphoma (NHL). The Kite Medical Hub is a non-promotional website intended for healthcare professionals in the UK and Ireland, designed, built and funded by Kite, a Gilead Company.

October 2020

eRMM Tool

Welcome to eRMM Tool an interactive training tool on the management of cytokine release syndrome and neurotoxicity in your YESCARTA® (axicabtagene ciloleucel) CAR T patients.

A CAR T patient avatar will take you on their treatment journey: from preparing your delivery centre, handling and administering treatment to managing any side effects promptly.

Upon completing a quiz at the end, you will be awarded an accredited CPD Certificate.


October 2020

Additional monitoring required.

Adverse events should be reported. For the UK, reporting forms and information can be found at via the Yellow Card app (download from the Apple App Store or Google Play Store). Adverse events should also be reported to Gilead at or +44 (0) 1223 897500.
Adverse events should be reported. For Ireland, reporting forms and information can be found at and can be reported to HPRA on +353 1 6764971. Adverse events should also be reported to Gilead at or +44 (0) 1223 897500.

Latest podcast

See more podcasts
02 Nov 2020
(DURATION: 32:05 - 59 MB)

Patient Perspectives: Long-Term Psycho-Social Impact of CAR T Back in the Community

Mr Stephen Scowcroft discusses the work of Lymphoma Action in wellbeing and education in patients receiving CAR T therapy, including the key role it plays in facilitating the voice of patients affected by lymphoma and how to improve the system going forward.

This podcast is intended for UK & Ireland HCPs who have registered with this Kite-owned website; please do not copy or distribute any content.

Play Podcast

Latest events

See more events
14 Sep 2020

GIO-Med virtual event 2020

Explore highlights from this year’s Gilead Immuno-Oncology Medical Education (GIO-Med) virtual event, broadcast as a series of pre-recorded educational videos and podcasts.

Join leading experts featured in the field of immuno-oncology as they discuss managing patients with diffuse large B-cell lymphoma (DLBCL) in clinical practice.

View event

CAR T, chimeric antigen receptor T-cell; DLBCL, diffuse large B-cell lymphoma; HCP, healthcare professional; KCH, King’s College Hospitals; NHL, non-Hodgkin lymphoma; UK, United Kingdom.